$EGRX EAGLE PHARMACEUTICALS, INC. Insider Trading Week 12/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EAGLE PHARMACEUTICALS, INC. in week 12/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 5,000 | 63,150 | 15,000 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,025 | 25,657 | 4,850 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,077 | 26,316 | 6,875 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 5,023 | 22,202 | 457 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 82.06 | 7,025 | 576,489 | 0 | 7 K to 0 (-100.00 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 5,000 | 63,150 | 7,025 | 2 K to 7 K (+246.91 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,025 | 25,657 | 2,025 | 0 to 2 K |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.09 | 7,100 | 568,641 | 0 | 7.1 K to 0 (-100.00 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,077 | 26,316 | 7,100 | 5 K to 7.1 K (+41.35 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 5,023 | 22,202 | 5,023 | 0 to 5 K |
| Mar 23 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.01 | 700 | 58,107 | 3,778,087 | 3.8 M to 3.8 M (-0.02 %) |
| Mar 23 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.10 | 500 | 41,550 | 3,778,787 | 3.8 M to 3.8 M (-0.01 %) |
| Mar 22 2017 | EGRX | EAGLE PHARMACEUTIC ... | Edlin Richard A. | Director | Buy | P | 79.44 | 6,000 | 476,640 | 29,400 | 23.4 K to 29.4 K (+25.64 %) |
| Mar 21 2017 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Buy | P | 83.98 | 61 | 5,123 | 511 | 450 to 511 (+13.56 %) |
| Mar 21 2017 | EGRX | EAGLE PHARMACEUTIC ... | Edlin Richard A. | Director | Option Exercise | A | 81.27 | 10,000 | 812,700 | 10,000 | |
| Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.10 | 51,883 | 4,259,594 | 3,779,287 | 3.8 M to 3.8 M (-1.35 %) |
| Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.01 | 38,997 | 3,198,144 | 3,831,170 | 3.9 M to 3.8 M (-1.01 %) |
| Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.08 | 9,120 | 748,570 | 3,870,167 | 3.9 M to 3.9 M (-0.24 %) |